{"id":"https://openalex.org/W2008164744","doi":"https://doi.org/10.1016/j.biomaterials.2003.12.034","title":"Biological evaluation and drug delivery application of cationically modified phospholipid polymers","display_name":"Biological evaluation and drug delivery application of cationically modified phospholipid polymers","publication_year":2004,"publication_date":"2004-01-30","ids":{"openalex":"https://openalex.org/W2008164744","doi":"https://doi.org/10.1016/j.biomaterials.2003.12.034","mag":"2008164744","pmid":"https://pubmed.ncbi.nlm.nih.gov/15120525"},"language":"en","primary_location":{"id":"doi:10.1016/j.biomaterials.2003.12.034","doi":"https://doi.org/10.1016/j.biomaterials.2003.12.034","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.biomaterials.2003.12.034","pdf_url":null,"source":{"id":"https://openalex.org/S163807576","display_name":"Biomaterials","issn_l":"0142-9612","issn":["0142-9612","1878-5905"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biomaterials","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5003642144","display_name":"Rosemary R. Palmer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150569","display_name":"Biocompatibles (United Kingdom)","ror":"https://ror.org/03sr1zw68","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210150569"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Rosemary R. Palmer","raw_affiliation_strings":["Biocompatibles UK Ltd., Drug Delivery, Chapman House, Farnham Business Park, Weydon Lane, Farnham, Surrey GU9 8QL, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biocompatibles UK Ltd., Drug Delivery, Chapman House, Farnham Business Park, Weydon Lane, Farnham, Surrey GU9 8QL, UK","institution_ids":["https://openalex.org/I4210150569"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032609290","display_name":"Andrew L. Lewis","orcid":"https://orcid.org/0000-0001-5779-5631","observed_orcids":["https://orcid.org/0000-0001-5779-5631"]},"institutions":[{"id":"https://openalex.org/I4210150569","display_name":"Biocompatibles (United Kingdom)","ror":"https://ror.org/03sr1zw68","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210150569"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Andrew L. Lewis","raw_affiliation_strings":["Biocompatibles UK Ltd., Drug Delivery, Chapman House, Farnham Business Park, Weydon Lane, Farnham, Surrey GU9 8QL, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biocompatibles UK Ltd., Drug Delivery, Chapman House, Farnham Business Park, Weydon Lane, Farnham, Surrey GU9 8QL, UK","institution_ids":["https://openalex.org/I4210150569"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081848015","display_name":"Laura C Kirkwood","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150569","display_name":"Biocompatibles (United Kingdom)","ror":"https://ror.org/03sr1zw68","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210150569"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Laura C. Kirkwood","raw_affiliation_strings":["Biocompatibles UK Ltd., Drug Delivery, Chapman House, Farnham Business Park, Weydon Lane, Farnham, Surrey GU9 8QL, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biocompatibles UK Ltd., Drug Delivery, Chapman House, Farnham Business Park, Weydon Lane, Farnham, Surrey GU9 8QL, UK","institution_ids":["https://openalex.org/I4210150569"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055048535","display_name":"Susanna F Rose","orcid":"https://orcid.org/0000-0003-4793-6909","observed_orcids":["https://orcid.org/0000-0003-4793-6909"]},"institutions":[{"id":"https://openalex.org/I71637028","display_name":"University of Brighton","ror":"https://ror.org/04kp2b655","country_code":"GB","type":"education","lineage":["https://openalex.org/I71637028"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Susanna F. Rose","raw_affiliation_strings":["School of Pharmacy and Biomolecular Sciences, Biomedical Materials Group, University of Brighton, Moulsecoomb, Brighton, East Sussex BN2 4GJ, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Pharmacy and Biomolecular Sciences, Biomedical Materials Group, University of Brighton, Moulsecoomb, Brighton, East Sussex BN2 4GJ, UK","institution_ids":["https://openalex.org/I71637028"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079822735","display_name":"Andrew W. Lloyd","orcid":"https://orcid.org/0000-0003-2778-8195","observed_orcids":["https://orcid.org/0000-0003-2778-8195"]},"institutions":[{"id":"https://openalex.org/I71637028","display_name":"University of Brighton","ror":"https://ror.org/04kp2b655","country_code":"GB","type":"education","lineage":["https://openalex.org/I71637028"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Andrew W. Lloyd","raw_affiliation_strings":["School of Pharmacy and Biomolecular Sciences, Biomedical Materials Group, University of Brighton, Moulsecoomb, Brighton, East Sussex BN2 4GJ, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Pharmacy and Biomolecular Sciences, Biomedical Materials Group, University of Brighton, Moulsecoomb, Brighton, East Sussex BN2 4GJ, UK","institution_ids":["https://openalex.org/I71637028"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046682792","display_name":"T. A. Vick","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150569","display_name":"Biocompatibles (United Kingdom)","ror":"https://ror.org/03sr1zw68","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210150569"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Terry A. Vick","raw_affiliation_strings":["Biocompatibles UK Ltd., Drug Delivery, Chapman House, Farnham Business Park, Weydon Lane, Farnham, Surrey GU9 8QL, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biocompatibles UK Ltd., Drug Delivery, Chapman House, Farnham Business Park, Weydon Lane, Farnham, Surrey GU9 8QL, UK","institution_ids":["https://openalex.org/I4210150569"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5105470784","display_name":"Peter W. Stratford","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150569","display_name":"Biocompatibles (United Kingdom)","ror":"https://ror.org/03sr1zw68","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210150569"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Peter W. Stratford","raw_affiliation_strings":["Biocompatibles UK Ltd., Drug Delivery, Chapman House, Farnham Business Park, Weydon Lane, Farnham, Surrey GU9 8QL, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biocompatibles UK Ltd., Drug Delivery, Chapman House, Farnham Business Park, Weydon Lane, Farnham, Surrey GU9 8QL, UK","institution_ids":["https://openalex.org/I4210150569"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5032609290"],"corresponding_institution_ids":["https://openalex.org/I4210150569"],"apc_list":{"value":4640,"currency":"USD","value_usd":4640},"apc_paid":null,"fwci":4.2939,"has_fulltext":false,"cited_by_count":40,"citation_normalized_percentile":{"value":0.94761569,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"25","issue":"19","first_page":"4785","last_page":"4796"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10859","display_name":"Polymer Surface Interaction Studies","score":0.8862000107765198,"subfield":{"id":"https://openalex.org/subfields/2508","display_name":"Surfaces, Coatings and Films"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10859","display_name":"Polymer Surface Interaction Studies","score":0.8862000107765198,"subfield":{"id":"https://openalex.org/subfields/2508","display_name":"Surfaces, Coatings and Films"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.07620000094175339,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.019500000402331352,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/2-methacryloyloxyethyl-phosphorylcholine","display_name":"2-methacryloyloxyethyl phosphorylcholine","score":0.9409999847412109},{"id":"https://openalex.org/keywords/cationic-polymers","display_name":"cationic polymers","score":0.9300000071525574},{"id":"https://openalex.org/keywords/protein-adsorption","display_name":"protein adsorption","score":0.7289999723434448},{"id":"https://openalex.org/keywords/fibrinogen-binding","display_name":"fibrinogen binding","score":0.8700000047683716},{"id":"https://openalex.org/keywords/albumin-binding","display_name":"albumin binding","score":0.9900000095367432},{"id":"https://openalex.org/keywords/hemocompatibility","display_name":"hemocompatibility","score":0.8610000014305115},{"id":"https://openalex.org/keywords/platelet-activation","display_name":"platelet activation","score":0.9350000023841858},{"id":"https://openalex.org/keywords/drug-delivery","display_name":"drug delivery","score":0.6830000281333923},{"id":"https://openalex.org/keywords/controlled-release","display_name":"controlled release","score":0.753000020980835},{"id":"https://openalex.org/keywords/gene-therapy","display_name":"gene therapy","score":0.5680000185966492},{"id":"https://openalex.org/keywords/dna-delivery","display_name":"DNA delivery","score":0.7919999957084656},{"id":"https://openalex.org/keywords/coronary-stents","display_name":"coronary stents","score":0.9409999847412109},{"id":"https://openalex.org/keywords/restenosis","display_name":"restenosis","score":0.8629999756813049},{"id":"https://openalex.org/keywords/biomaterial-coatings","display_name":"biomaterial coatings","score":0.5130000114440918}],"concepts":[{"id":"https://openalex.org/C192562407","wikidata":"https://www.wikidata.org/wiki/Q228736","display_name":"Materials science","level":0,"score":0.7016068696975708},{"id":"https://openalex.org/C2779820397","wikidata":"https://www.wikidata.org/wiki/Q1392806","display_name":"Drug delivery","level":2,"score":0.6788740158081055},{"id":"https://openalex.org/C521977710","wikidata":"https://www.wikidata.org/wiki/Q81163","display_name":"Polymer","level":2,"score":0.5908121466636658},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.5765151977539062},{"id":"https://openalex.org/C2778918659","wikidata":"https://www.wikidata.org/wiki/Q186915","display_name":"Phospholipid","level":3,"score":0.550512969493866},{"id":"https://openalex.org/C171250308","wikidata":"https://www.wikidata.org/wiki/Q11468","display_name":"Nanotechnology","level":1,"score":0.46727123856544495},{"id":"https://openalex.org/C136229726","wikidata":"https://www.wikidata.org/wiki/Q327092","display_name":"Biomedical engineering","level":1,"score":0.437434583902359},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.34892046451568604},{"id":"https://openalex.org/C159985019","wikidata":"https://www.wikidata.org/wiki/Q181790","display_name":"Composite material","level":1,"score":0.17469432950019836},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.1559499204158783},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.12052732706069946},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.11602172255516052},{"id":"https://openalex.org/C41625074","wikidata":"https://www.wikidata.org/wiki/Q176088","display_name":"Membrane","level":2,"score":0.07460767030715942}],"mesh":[{"descriptor_ui":"D000042","descriptor_name":"Absorption","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000327","descriptor_name":"Adsorption","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001158","descriptor_name":"Arteries","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D001158","descriptor_name":"Arteries","qualifier_ui":"Q000601","qualifier_name":"surgery","is_major_topic":false},{"descriptor_ui":"D001780","descriptor_name":"Blood Coagulation Tests","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002412","descriptor_name":"Cations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002478","descriptor_name":"Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002794","descriptor_name":"Choline","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D002794","descriptor_name":"Choline","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D003331","descriptor_name":"Coronary Vessels","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D003331","descriptor_name":"Coronary Vessels","qualifier_ui":"Q000601","qualifier_name":"surgery","is_major_topic":false},{"descriptor_ui":"D005340","descriptor_name":"Fibrinogen","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008422","descriptor_name":"Materials Testing","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008689","descriptor_name":"Methacrylates","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D009841","descriptor_name":"Oligonucleotides","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D009841","descriptor_name":"Oligonucleotides","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D010743","descriptor_name":"Phospholipids","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D011485","descriptor_name":"Protein Binding","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012709","descriptor_name":"Serum Albumin","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D013552","descriptor_name":"Swine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015539","descriptor_name":"Platelet Activation","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":true},{"descriptor_ui":"D016503","descriptor_name":"Drug Delivery Systems","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D020099","descriptor_name":"Coated Materials, Biocompatible","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1016/j.biomaterials.2003.12.034","doi":"https://doi.org/10.1016/j.biomaterials.2003.12.034","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.biomaterials.2003.12.034","pdf_url":null,"source":{"id":"https://openalex.org/S163807576","display_name":"Biomaterials","issn_l":"0142-9612","issn":["0142-9612","1878-5905"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biomaterials","raw_type":"journal-article"},{"id":"pmid:15120525","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15120525","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biomaterials","raw_type":"Comparative Study"},{"id":"pmh:oai:pure.atira.dk:publications/0df5d1cc-ef6f-40c1-9e60-0d6a06dbf2b8","doi":null,"is_oa":false,"landing_page_url":"https://research.brighton.ac.uk/en/publications/0df5d1cc-ef6f-40c1-9e60-0d6a06dbf2b8","pdf_url":null,"source":{"id":"https://openalex.org/S4306401758","display_name":"University of Brighton Repository (University of Brighton)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I71637028","host_organization_name":"University of Brighton","host_organization_lineage":["https://openalex.org/I71637028"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Palmer, R R, Lewis, A L, Kirkwood, L C, Rose, S F, Lloyd, A, Vick, T A & Stratford, P W 2004, 'Biological evaluation and drug delivery application of cationically modified phospholipid polymers', Biomaterials, vol. 25, no. 19, pp. 4785-4796. https://doi.org/10.1016/j.biomaterials.2003.12.034","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.8048999905586243,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":31,"referenced_works":["https://openalex.org/W33330520","https://openalex.org/W58732351","https://openalex.org/W350039557","https://openalex.org/W1973692791","https://openalex.org/W1979422918","https://openalex.org/W1982954035","https://openalex.org/W1988136411","https://openalex.org/W1992308498","https://openalex.org/W1998463562","https://openalex.org/W2001531968","https://openalex.org/W2002896686","https://openalex.org/W2008215555","https://openalex.org/W2008600005","https://openalex.org/W2018605111","https://openalex.org/W2028032162","https://openalex.org/W2031778580","https://openalex.org/W2033048782","https://openalex.org/W2046583107","https://openalex.org/W2048816109","https://openalex.org/W2078731238","https://openalex.org/W2086162797","https://openalex.org/W2090948132","https://openalex.org/W2110347218","https://openalex.org/W2116362164","https://openalex.org/W2145565928","https://openalex.org/W2168894408","https://openalex.org/W2467249852","https://openalex.org/W2519044338","https://openalex.org/W3151294026","https://openalex.org/W4285719527","https://openalex.org/W6726950172"],"related_works":["https://openalex.org/W58732351","https://openalex.org/W2410703651","https://openalex.org/W2112811428","https://openalex.org/W2078731238","https://openalex.org/W4254619330","https://openalex.org/W2139455476","https://openalex.org/W1989286377","https://openalex.org/W1980126098","https://openalex.org/W2020768535","https://openalex.org/W1986012421"],"abstract_inverted_index":null,"counts_by_year":[{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":1},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}